Chronic Leukemia

Chronic Leukemia News

  • Alemtuzumab-Methylprednisolone in CLL With TP53 Deletion Alemtuzumab plus methylprednisolone was very effective at putting chronic lymphocytic leukemia (CLL) into remission in patients with TP53 deletion (17p-), in a mid-stage trial in the UK.
    Reuters Health Information, April 19, 2012
  • EPOCH-Rituximab With Fludarabine a Useful Bridge to HSCT For patients with aggressive lymphoid malignancies, EPOCH-rituximab with fludarabine can be an effective bridge to reduced-intensity conditioning and allogeneic hematopoietic stem-cell transplantation.
    Reuters Health Information, March 1, 2012
More
 

Chronic Leukemia Perspectives

  • Great New Drugs Will Be Harder to Come By Great New Drugs Will Be Harder to Come By   Dr. Bruce Cheson discusses the Cheson Rule for New Drug Approval, which states (rather paradoxically) that the more effective a drug is, the more it negatively affects future drug development.
    Medscape Hematology-Oncology, December 29, 2011
  • A Dickensian CLL Story   Drs. Bruce Cheson and Clemens Wendtner visit ghosts of CLL treatment past, present, and future.
    Medscape Hematology-Oncology, December 23, 2011
More
 

Journals

More
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.